Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-27 12:47:43 - browse：494

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： WHO calls for emergency meeting on new China virus, as cases spread

WSS

After sickle

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Teach medical students about patients with intellectual disabilities

Spinal cord stimulation reduces pain in amputees, study finds

FDA approves world's first CRISPR

SCOTUS to consider access to abortion pill mifepristone

focus

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

Hollywood unions extend contract negotiations for actors

How Medicaid coverage policies for immigrants impact new moms

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Heart attack and stroke risk calculators need revising

Medicare to cover more brain scans for Alzheimer’s patients

At least 13 dead in Texas as scorching temps continue

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

United colonoscopy coverage change 'may cost lives,' doctors say

STAT Virtual Event: The State of Biosimilars: What to Watch

hotspot

Custom gene therapy hints at new path for rare disease treatments

Leukemia patients are helped by Syndax's new type of therapy

Google and Epic fight stronger regulation of AI in health care

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Medicare to cover more brain scans for Alzheimer’s patients

Teach medical students about patients with intellectual disabilities

Wikipedia

knowledge

entertainment

hotspot